Trial intelligence / Profile preview

Feasibility of Adjuvant S-1 in NSCLC

NCT01459185Phase 2Completed

Start
Jun 2005
Primary completion
May 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tegafur in non-small cell lung cancer (NSCLC). Started Jun 2005; status: completed.

02

Drugs

tegafur
03

Conditions

non-small cell lung cancer (NSCLC)

Beyond the preview

Go deeper on NCT01459185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01459185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call